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ABSTRACT 
Hepatic venous outflow obstruction (HVOO) is a rare complication after liver transplantation (LT) 
associated with significant morbidity and reduced graft survival. Endovascular intervention has 
become the first line treatment for HVOO, but data on long-term outcomes is lacking. We have 
analysed outcomes after endovascular intervention for HVOO in 905 consecutive patients who 
received 965 full-size LT at our unit from January 2007 to June 2014. There were 27 (3%) patients 
who underwent hepatic venogram for suspected HVOO, with persistent ascites being the most 
common symptom triggering the investigation (n=19, 70%). Of those, only 10 patients demonstrated 
either stricture or pressure gradient over 10 mmHg on venogram, which represents a 1% incidence of 
HVOO. The endovascular interventions were balloon dilatation (n=3), hepatic vein stenting (n=4) and 
stenting with dilatation (n=3). Two patients required re-stenting due to stent migration. The symptoms 
of HVOO completely resolved in all but one patient, with a median follow up period of 74 (inter 
quartile range 39 – 89) months. There were no procedure related complications or mortality. In 
conclusion, the incidence of HVOO in patients receiving full-size LT is currently very low. 
Endovascular intervention is an effective and safe procedure providing symptom relief with long-
lasting primary patency. 
 
INTRODUCTION: 
Liver transplantation (LT) is the treatment of choice for patients with end-stage chronic liver disease, 
early stages of liver cancer and fulminant hepatic failure. Over the past 4 decades, the surgical 
technique has evolved significantly, with a concomitant fall in morbidity and mortality [1]. Initially, 
LT were performed using caval replacement, but this was associated with hemodynamic instability [2, 
3]. Calne and Williams first introduced caval preservation in 1968, and this was reintroduced 20 years 
later and termed “piggyback” technique and has gained widespread acceptance [4-6].  
Hepatic venous outflow obstruction (HVOO), so called “piggyback syndrome”, is a rare but 
potentially lethal complication after LT [7-10]. HVOO is more commonly associated with use of 
partial liver grafts, with a reported incidence between 1.5% to 4% compared to a rate of 1% after full-
size LT [11-15]. HVOO can occur in the early post-operative period, possibly from direct 
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compression of the hepatic veins, but can also occur several months to years later from fibrotic 
changes at the anastomosis [16-18].  
Hepatic venous stenosis presents with ascites, variceal haemorrhage, splenomegaly and abnormal 
liver and kidney function [19]. Early detection of HVOO is important as the liver graft dysfunction 
can result from congestion, and timely intervention such as balloon angioplasty or stent placement can 
preserve graft function [11, 20-23]. Long-term follow-up data after endovascular treatment for HVOO 
is lacking. We present the long-term follow-up of our experience with management of HVOO in a 
large single centre series. 
 
PATIENTS AND METHODS:  
Study design and patients 
Retrospective analysis of a prospectively maintained database of patients who had liver 
transplantation at the Liver Unit in Birmingham between 1st January 2007 and 30th June 2014 was 
performed. The start of the study period coincided with the transition from film-based to digital-based 
imaging in our radiology department.  
There was a total of 1086 liver transplant procedures performed on 1026 patients. One hundred and 
twenty-one procedures were performed with partial grafts (116 right lobe grafts and 5 left lobe grafts, 
including 7 live donor liver transplants). These patients were excluded from the study. Nine hundred 
and five patients who received full-size liver grafts were included in our study. From this cohort we 
identified patients who developed symptoms suspicious of HVOO and collected their demographic 
details, indication for liver transplantation, clinical presentation of suspected HVOO, venograms, and 
details of endovascular interventions. Data regarding symptom relief was collected during clinic 
follow-up appointments and the date of last follow-up in this study was 31st March 2016. A range of 
donor- and organ-related factors were compared between those patients that did and did not develop 
HVOO.  Overall patient and graft survival and survival with and without HVOO were compared. 
The primary study endpoints were resolution of symptoms and post-transplant survival. Any stent-
related complications were recorded according to Clavien-Dindo classification [24]. The procedure-
related death was defined as any mortality within 90 days following the intervention.  
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Surgical technique of the hepatic venous outflow reconstruction 
Liver transplants were performed by a team of eight transplant surgeons using piggyback technique. 
The unit changed from the inferior vena cava (IVC) replacement to piggyback implantation technique 
in 2000.  The technical detail of the piggyback technique and its modifications are shown in Figure 1. 
Six surgeons performed modified piggyback implantation as popularised by Belghiti, with both ends 
of the IVC closed and large side-to-side caval anastomosis (variant 1) [5]. One surgeon each 
performed side-to-side cavocavostomy with upper open end of the IVC included in the anastomosis 
(variant 2) and classical technique creating anastomosis between the supra hepatic part of the donor 
IVC and the common orifice of left and middle hepatic veins (variant 3) [25]. With all approaches the 
native IVC flow was maintained throughout the implantation period.  
The anastomosis was performed with a continuous, non-absorbable polypropylene 4-0 suture 
(Prolene, Ethicon Inc., USA).  In the case of the longitudinal cavo-cavostomy the recipient IVC 
venotomy was performed as close to the diaphragm as technically feasible, usually placing the upper 
corner of the anastomosis above the level of the native hepatic veins (Figure 2). For the side-to-side 
technique, with both ends of the donor IVC closed, the graft venotomy was positioned as close to the 
suprahepatic IVC suture line as possible 
 
Post-transplant immunosuppression and follow-up 
Post-transplant immunosuppression consisted of tacrolimus-based therapy in combination with either 
azathioprine or mycophenolate mofetil, and a three-month course of prednisolone. All patients 
received aspirin 75mg daily as standard long-term prophylaxis of hepatic artery thrombosis.  
After discharge from hospital, patients were followed up on a weekly (first 6 weeks) then fortnightly 
(after 6 weeks) basis until 3 months after transplantation. Each outpatient consultation consisted of a 
clinical review and blood analysis including liver function tests.  
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Hepatic venous outflow obstruction diagnosis and interventions 
The clinical symptoms triggering the suspicion of HVOO were persistent ascites, lower extremity 
oedema, pleural effusion and deranged liver function. All patients with any of those symptoms 
underwent Doppler liver ultrasound and subsequently hepatic venography, performed through 
transjugular approach in all patients. All patients diagnosed with HVOO on hepatic venography (slow 
flow across the anastomosis, pressure gradient greater than 10 mmHg across the anastomosis and 
stenosis at the anastomosis) were treated with venoplasty with 10-12 mm balloon initially. If the 
pressure gradient was persistently high and/or residual stenosis was present even after venoplasty on 
check venogram, then they were treated with a 10-12 mm self-expanding uncovered stent (Boston 
Scientific Vascular Wallstent) during the index procedure. Patients who had persistent symptoms 
post-procedure were subjected to repeat venogram. Again during the second venogram, venoplasty 
was initially attempted, but patients with high-pressure gradient and/or residual stenosis after 
venoplasty were stented. Two experienced interventional liver radiologists performed all interventions 
and the findings were discussed at a multi-disciplinary liver transplant meeting. Patients who had no 
evidence of HVOO on hepatic venography were treated with diuretics rather than endovascular 
therapy.  
 
Statistical analysis 
Continuous variables were presented as median with interquartile range and the categorical variables 
were presented as numbers and percentages. Survival was calculated using Kaplan-Meier method. 
Univariate analysis was performed to assess the relationship between HVOO and various donor- and 
graft-related factors. SPSS software (version 22.0, SPSS Inc. Chicago, IL, USA) was used to perform 
statistical analysis. For presenting the results, percentages were rounded to whole numbers and p-
values to three decimals.  
RESULTS:  
905 patients received 965 full-size graft transplants over the study period. Among these 60 were re-
transplantations for various indications, but none of the re-transplants were performed for HVOO. 
Only 27 (3%) patients developed symptoms suggestive of HVOO. These cases constituted the 
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presented series cohort and are shown in Table 1. Caval anastomosis was performed as variant 1 in 
691, variant 2 in 97 and variant 3 in 117 patients. Among the symptomatic patients twenty-six patients 
had caval reconstruction with side-to-side cavostomy (variant 1) and one patient had the donor supra-
hepatic IVC reconstruction to the recipient left and middle hepatic veins (variant 3; this patient did not 
have proven HVOO on venogram) (Table 2). 
 
The median time between transplantation and development of symptoms suggestive of HVOO was 3 
(interquartile range (IQR) 1.7 - 6.9) months, with the overall follow up period of 101 months. The 
most common presenting symptom was ascites (n=19, 70%). Other symptoms suggestive of HVOO 
were deranged liver function (n=5), lower extremity oedema (n=5), pleural effusion (n=3) and 2 
patients had evidence of venous congestion on liver biopsy. These symptomatic patients underwent 
percutaneous hepatic venogram with pressure measurements in right atrium, IVC and hepatic veins. 
Ultrasound findings suggestive of HVOO (disappearance of pulsatile hepatic venous outflow or 
flattening of the hepatic venous waves) were present only in 4 of our 27 (15 %) patients. Liver biopsy 
findings of HVOO were congestion, haemorrhage and necrosis around the central veins, and were 
present in 2 patients (7%).  Only 10 of the 27 (37%) patients with symptoms concerning for HVOO 
had a hepatic venous pressure gradient greater than 10 mmHg or venogram suggestive of stricture and 
all these patients had side-to-side cavo-cavostomy anastomosis. This yields an overall incidence of 
HVOO in our series of 1.1%. 
 
Among the 10 patients with positive venogram, 3 patients who had high pressure gradient or stenosis 
at the anastomosis were treated only with hepatic venoplasty (Figure 2). Four patients with persistent 
high pressure gradient, even after venoplasty on check venogram, were treated with hepatic venous 
stenting during the index venogram (Figure 3). Three patients were treated initially with hepatic 
venoplasty, but, due to persistent symptoms and pressure gradient/residual stenosis on a subsequent 
venogram even after repeat venoplasty, they underwent hepatic vein stenting. In all patients pressure 
gradient of <10 mmHg and/or disappearance of stenosis was confirmed with post-venoplasy/stenting 
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venograms. The median post-transplant and post-procedure follow-up periods were 76 (IQR 54 – 91) 
months and 74 (IQR 39 – 89) months respectively.  
 
In all patients in the intervention group the symptoms of HVOO resolved completely. Of 2 patients in 
this group who had deranged liver function tests along with other symptoms of HVOO before the 
procedure, 1 had stenting and the liver function became normal during follow-up, and 1 patient had 
hepatic venoplasty and was scheduled to undergo stenting, but was lost to follow up due to non-
compliance and this patient died 28 weeks later from opioid overdose and non-compliance with 
immunosuppression.  
 
During follow-up 2 patients were found to have stent migration, requiring re-stenting and 1 patient 
had repeated balloon dilatation for persistent ascites (Figure 4). There was no procedure-related 
mortality in our series. Of the patients who underwent intervention for HVOO, 2 patients died during 
follow-up from causes unrelated to HVOO (meningioma and chronic rejection after a 4th LT).  
 
Of the 17 patients with symptoms of HVOO but no HV pressure gradient or venogram findings 
suggestive of HVOO, (and therefore no intervention performed) 2 patients died. One of these patients 
died from squamous cell carcinoma of the ear and the other from hepatitis C recurrence.  
 
On univariate analysis donor-related factors (donor age, height, weight and BMI) and graft-related 
factors (cold ischaemic time, graft steatosis, surgeons’ pre-transplant assessment about the graft) were 
analysed between patients with and without HVOO. None of these comparisons were found to be 
significant (Table 3). However, due to the small sample size in the HVOO group, the statistical power 
of this analysis was low.  Overall patient and graft survival were calculated for the whole study 
period. Patient and graft survival were compared separately for patients with and without HVOO. 
(Table 2 and Figure 5)  
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DISCUSSION:  
Hepatic venous outflow obstruction due to anastomotic stricture is a very rare complication after liver 
transplantation in adult recipients who receive full-size liver grafts in a piggyback technique [26]. 
HVOO early after liver transplantation is associated with high morbidity and mortality; almost one-
third of patients will require re-transplantation if surgical and endovascular interventions fail [27, 28]. 
HVOO occurring in the early postoperative period is thought to be secondary to several factors, such 
as a tight suture line, kinking of a redundant hepatic vein, donor recipient size discrepancy, or caval 
compression from a large graft [14]. HVOO occurring after the first 3 months is thought to arise from 
fibrosis of the anastomotic site and intimal hyperplasia [14]. Vilca et al reported that caval 
replacement technique has the advantages of wider retro-hepatic cava which avoids venous outflow or 
caval obstruction [29].     
 
The existing literature describes an incidence of HVOO after full-size graft liver transplantation 
between 0.8 – 1 % concurrent with our incidence of 1% [22, 28]. It is well documented that the 
incidence of HVOO is higher in patients receiving partial liver grafts, ranging between 3.9 – 16.6% 
[13, 21, 23, 30]. This is likely due to the fact that the anastomosis of the hepatic veins to the IVC in 
partial grafts is smaller [31, 32]. Additionally, partial liver grafts usually grow considerably after 
transplantation, so the hepatic venous outlet might be compromised by distortion of the outlet [26, 
33].   
 
Patients with hepatic venous outflow obstruction usually present with large volume ascites, which is 
refractory to diuretic therapy and protein supplementation, and bilateral lower limb oedema [22, 28]. 
Clinically significant early post-transplant HVOO usually causes deterioration of liver and renal 
function. In some patients HVOO can also cause symptoms including ascites and renal dysfunction 
without deterioration of hepatic function [34]. In either case, early treatment of HVOO is critical to 
prevent morbidity and mortality [35-37].  
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In our series the most commonly described symptom was ascites, present in 76% of our patients with 
suspected HVOO, but 27% of patients with a positive venogram. Deranged liver function, lower 
extremity oedema and pleural effusions are some of the other symptoms in our series. In 2 patients, 
liver biopsy demonstrated evidence of hepatic venous congestion, leading to an eventual diagnosis of 
HVOO.  
 
Doppler ultrasound is a useful screening test in patients suspected of having HVOO, when a 
dampened waveform with decreased mean velocity in the hepatic veins is seen [38]. If significant 
stenosis develops, the waveform usually degrades to a monophasic pattern, and in some cases reversal 
of flow in the hepatic veins can be demonstrated [39-41]. Reduced pulsatility is associated with 
transplant hepatic vein stenosis [42]. The venous pulsatility index, described by Coulden et al and 
Chong et al, can be used to increase the specificity of Doppler ultrasound [43, 44]. 
 
Venography and measurement of pressures within the hepatic veins is the confirmatory test of choice 
in patients suspected of having HVOO [19, 45].  There is no consensus on the hepatic vein pressure 
gradient that is significant in a patient suspected of having HVOO, and pressure gradients from 3 to 
20 mmHg have been reported as the threshold of clinical significance [40].  A gradient greater than 10 
mmHg between the hepatic vein and the right atrium is most commonly used for the diagnosis of 
HVOO [11, 46]. In our study presence of HVOO symptoms with a gradient of 10 mmHg and/or 
stricture on venogram was an indication for intervention. 
 
Therapeutic options for HVOO include angioplasty with or without stent placement, surgical 
reconstruction of the venous anastomosis, and re-transplantation [47]. Hepatic venous outflow 
obstruction immediately after transplantation can be treated with surgical revision of the HV 
anastomosis [23, 47, 48]. Conversely, late-onset hepatic venous outflow obstruction produces 
insidious deterioration of liver and kidney function, and surgical correction is difficult, thus, 
endovascular interventions are preferred [15, 49-52]  
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In our series there were no patients with early HVOO requiring reoperation or re-transplantation. The 
median duration between liver transplantation and the development of symptoms requiring venogram 
was 3 months. This was considered late onset HVOO, and was treated with venoplasty and/or 
stenting.   
 
Ten of the 27 patients with suspected HVOO had a pressure gradient over 10 mmHg and/or stricture 
at the anastomosis. All of these patients were initially treated with balloon dilatation, unless there was 
a persistent high pressure gradient on the check venogram. In such cases, a stent was placed during 
the index venogram (n=4). Hypotension, arrhythmia, stent occlusion, restenosis and stent migration 
are some reported complications of hepatic vein stents [33]. In our study, 2 out of 7 patients who were 
stented developed stent migration requiring a second stent. None of our patients developed a 
procedure-related complication. Symptoms resolved in all treated patients, except the patient who did 
not attend the appointment for stent placement.  
 
Repeated balloon dilatation or stent placement after the venoplasty may be required for persistent 
symptoms of HVOO and high pressure gradient or recurrent stenosis. In our study, 1 patient required 
a second balloon dilatation, and 3 patients required stenting after dilatation. For refractory cases 
formal reconstruction of outflow may be required. Quintini et al suggested a side-to-side cavostomy 
using GIA stapler [47].  There was no need for any surgical intervention in our patients for HVOO.  
The literature describing the management of HVOO after full-size graft liver transplantation is 
dominated by case reports [53]. Most of the available literature on HVOO is from experiences in 
living donor transplantation [33]. Quintela et al reported their experience with end-to-side cavo-
cavostomy for early hepatic venous outflow obstruction with 45-month follow up, but there are no 
reports of long-term follow-up after endovascular intervention [31]. With the median follow-up of 74 
months and maximum overall follow-up of 101 months, none of our patients required surgical 
intervention for HVOO, indicating that the combination of balloon angioplasty and/or stenting has 
long-term success in the management of HVOO. 
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On further analysis no risk factors have been identified that may be related to development of this 
complication. In accordance with previous reports we observed perhaps more cases with HVOO in 
patients transplanted for Budd-Chiari syndrome [54, 55]. The relatively higher incidence in patients 
undergoing liver re-transplantation might be explained by the technical aspects of the challenging 
procedure, with possible kinking or twisting of the IVC anastomosis, performed usually on the IVC 
cuff remaining from the failed graft. For the recipients with fulminant liver failure we can speculate 
that HVOO might be related to cases when the procedure urgency might have led to usage of size-
mismatched organs, with a relatively large graft compressing the venous outflow. It would be 
interesting to perform prospective analyses to detect factors associated with HVOO, which could be 
used to identify patients at risk of the complication. The inability to perform this represents a 
limitation of this report, but due to the infrequency of HVOO occurrence, this would require a large, 
multi-centre transplant registry study to collect a sufficient sample size to attain adequate statistical 
power for the detection of clinically relevant associations.  
 
We conclude that the incidence of HVOO in patients receiving full–size liver transplantation is 1 %. 
Endovascular intervention is effective with negligible procedure-related morbidity. The median 
follow-up period of 74 months after treatment demonstrates that endovascular treatments provide 
symptom relief with long-lasting primary patency, with only 3 patients requiring repeated 
interventions. 
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FIGURE LEGENDS  
Figure 1: Study inclusion flow chart 
Figure 2: Technical aspects and variants of the piggyback anastomosis 
The figure highlights technical aspects of the piggyback hepatic venous outflow reconstruction. Panel 
A demonstrates back-table preparation of the graft IVC with the divided retrocaval ligament, exposing 
the posterior aspect of the retrohepatic IVC; this preparation is not necessary for the conventional 
piggyback technique (see below). Panel B shows the incision in the posterior aspect of the 
suprahepatic IVC, and orifices of all the three hepatic veins. Panel C displays the recipient IVC after 
the native liver hepatectomy, the stump of the right hepatic vein divided with an endo-GIA vascular 
stapler in the longitudinal direction, and the stump of the left and middle hepatic veins in the 
transverse direction close to the diaphragm. Panel D illustrates the Babcock clamps used to apply 
traction on the anterior aspect of the IVC wall to facilitate placement of a large Satinsky clamp as 
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demonstrated on Panel E, preserving approximately 50% of the vascular flow.  Panel F displays the 
longitudinal venotomy with placed stay sutures in preparation for the side-to-side venoplasty. Panel 
G shows a suture in the inferior and Panel H a suture in the superior corners of the donor IVC. Panel 
I demonstrates the sutured right-side of the caval anastomosis. Panel J shows the right-side lateral 
view of the implanted liver graft. Panel K shows the recipient IVC opening used to perform side-to-
side modified (left) or end-to-side traditional piggyback anastomosis. Panel L displays the lateral 
view of the post-implantation anatomical situation in variants 1 (top) and 2 (middle) of side-to-side 
cavostomy; the bottom drawing shows traditional piggyback anastomosis of the donor suprahepatic 
IVC to the orifices of the left and middle hepatic veins.  
 
Figure 3: Venogram of a patient with hepatic venous outflow obstruction 
Hepatic venogram shows narrowing at the anastomosis level (Panel A) treated with balloon 
venoplasty (Panel B). The post-intervention venogram demonstrates resolved stenosis and improved 
hepatic outflow (Panel C). 
 
Figure 4: Venogram of a patient undergoing hepatic venous outflow stenting 
The figure shows hepatic venogram with narrowing at the anastomosis level prior (Panel A) and after 
(Panel B) the stent insertion.  
 
Figure 5: Patient and graft survival 
Panel A demonstrates the Kaplan Meyer curves with the overall patient (full line) and graft (dotted 
line) survivals of all 965 full-size liver transplant recipients transplanted over the study period. Panel 
B shows the overall survival of patients without (blue line), respective with proven (red line) hepatic 
venous outflow obstruction. Panel C shows the graft survival in the same groups of patients.  
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Table 1: Recipient indication for liver transplantation 
 All patients                             
(n=965) 
Patients with suspected HVOO 
(n=27) 
Patients with proven HVOO 
(n=10) 
Fulminant hepatic failure 1 100 4 2 
Hepatocellular carcinoma 2 164 1 2 
Hepatitis C Virus 91 3 0 
Primary biliary cirrhosis 102 3 0 
Primary sclerosing cholangitis 89 2 1 
Alcohol-related liver disease 150 2 1 
Autoimmune hepatitis 25 2 1 
Budd-Chiari Syndrome 8 2 1 
Alpha-1 anti-trypsin deficiency 13 2 1 
Non alcoholic steatohepatitis 40 2 0 
Nodular regenerative hyperplasia 12 1 0 
Polycystic liver disease 20 1 0 
Cryptogenic cirrhosis 22 1 0 
Re-transplantation 2 60 1 1 
Others 69 0 0 
Abbreviations: 
HVOO, hepatic venous outflow obstruction 
Note: 
1 Indication included fulminant liver failure caused by paracetamol overdose, seronegative and drug-induced hepatitis, 2 Various aetiology or indication 
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Table 2: Patient and graft survival 
 All patients                             
(n=965) 
Patients with suspected HVOO 
(n=27) 
Patients with proven HVOO 
(n=10) 
Piggyback surgical reconstruction    
Variant 1 751 26 10 
Variant 2 97 0 0 
Variant 3 117 1 0 
1-year graft survival 86% 100% 100% 
5-year graft survival 76% 82% 70% 
1-year patient survival 90 % 100% 100% 
5-year patient survival 79% 87% 80% 
Abbreviations: 
HVOO, hepatic venous outflow obstruction 
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Table 3: Risk factors for hepatic venous outflow obstruction 
 HVOO  
 
No 
(n=895) 
Yes 
(n=10) 
p-value 
Donor age (years) 50 ± 15 50 ± 15 1.000 
Donor height (cm) 169 ± 11 171 ± 10 0.523 
Donor weight (kg) 75 ± 15 79 ± 10 0.441 
Body mass index (kg/m2) 26 ± 5 27 ± 4 0.644 
Cold ischemic time (minutes) 487 ± 135 555 ± 117 0.113 
Steatosis 75 (8%) 1 (10%) 0.586 
Sub-optimal organ 283 (32%) 1 (10%) 0.185 
Abbreviations: 
HVOO, hepatic venous outflow obstruction 
Note:  
Data reported as mean ± standard deviation with p-values from t-tests, or N (%) with p-value from Fisher’s exact test, as applicable. This analysis 
includes only 905 patients who received primary transplant with full-size graft 
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